FDA recall D-0244-2026

Product

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Reason for recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

Distribution

Nationwide within the United States.

Key facts

Status

Ongoing

Initiation date

2025-12-19

Report date

2026-01-07

Voluntary/Mandated

Voluntary: Firm initiated

Location

Plainsboro, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0244-2026